KTRA5:00 PMTuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate UpdateEnrollment • Phase 3Enrollment completion Wed, Jun 30, 2027tuhurabio.com
KTRA7:30 AMTuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conferencetuhurabio.com
KTRA7:30 AMTuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028tuhurabio.com
KTRA7:45 AMTuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operationstuhurabio.com
KTRA7:45 AMTuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Updatetuhurabio.com
KTRA7:45 AMCraig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancerstuhurabio.com